Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Mayo Clinic 17
Testing effectiveness (Phase 2)WithdrawnNCT03312894
What this trial is testing

Efficacy and Safety of TAK-653 in Treatment-Resistant Depression

Who this might be right for
Treatment-Resistant Depression
Millennium Pharmaceuticals, Inc.
Not applicableStudy completedNCT01836146
What this trial is testing

International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension

Who this might be right for
HypertensionRenal Denervation
Abbott Medical Devices 39
Early research (Phase 1)Study completedNCT02655822
What this trial is testing

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Who this might be right for
Renal Cell CancerMetastatic Castration Resistant Prostate Cancer
Corvus Pharmaceuticals, Inc. 502
Testing effectiveness (Phase 2)Study completedNCT00028873
What this trial is testing

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 35
Post-approval studies (Phase 4)WithdrawnNCT03408405
What this trial is testing

ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children

Who this might be right for
Steroid-Resistant Nephrotic Syndrome
Rhode Island Hospital
Testing effectiveness (Phase 2)Study completedNCT00364026
What this trial is testing

A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs

Who this might be right for
Hypertension
Gilead Sciences
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Post-approval studies (Phase 4)Active Not RecruitingNCT07258225
What this trial is testing

Clinical Effectiveness of a Once-daily Regimen of Tigecycline Compared to the Standard Regimen

Who this might be right for
Multi Drug Resistant Infections
Air Force Specialized Hospital, Cairo, Egypt 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06978023
What this trial is testing

Novel Chinese Medicine Formula for Diabetes

Who this might be right for
Type 2 Diabetes
Chinese University of Hong Kong 162
Testing effectiveness (Phase 2)Study completedNCT03672240
What this trial is testing

Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment

Who this might be right for
Non-Muscle Invasive Bladder Cancer (NMIBC)
Asieris Pharmaceutical Technologies Co., Ltd. 6
Large-scale testing (Phase 3)UnknownNCT05040126
What this trial is testing

Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in India

Who this might be right for
Pre-Extensively Drug-Resistant Pulmonary TBTreatment Intolerant Multidrug-Resistant Pulmonary TBNon-responsive Multidrug-Resistant Pulmonary TB
Tuberculosis Research Centre, India 400
Large-scale testing (Phase 3)Study completedNCT00146718
What this trial is testing

Anti-Malarial Drug Resistance in Cameroon

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 755
Not applicableStudy completedNCT02895568
What this trial is testing

Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers

Who this might be right for
Plasmodium Falciparum
University of Oxford 399
Large-scale testing (Phase 3)Ended earlyNCT00319150
What this trial is testing

REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial

Who this might be right for
Kidney Failure, ChronicDrug Resistance
Queen's University 6
Post-approval studies (Phase 4)Study completedNCT00375843
What this trial is testing

Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication

Who this might be right for
Depression
National Institute of Mental Health (NIMH) 118
Testing effectiveness (Phase 2)Ended earlyNCT02625090
What this trial is testing

An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma SRL 42
Not applicableUnknownNCT02986490
What this trial is testing

Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
University Hospital, Montpellier 100
Not applicableLooking for participantsNCT05532397
What this trial is testing

Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma

Who this might be right for
Glioma, Astrocytic
National University Hospital, Singapore 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013
What this trial is testing

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Who this might be right for
Bladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more
Cancer Research UK 81
Next Page